6.65
price up icon1.84%   0.12
 
loading

Finanzdaten der Nextcure Inc-Aktie (NXTC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
134.83%
27.29
11.62 12.46 12.49 16.49
Operating Income/Loss
134.83%
-27.29
-11.62 -12.46 -12.49 -16.49
Income/Loss From Continuing Operations Before Tax
144.24%
-26.81
-10.98 -11.60 -11.54 -15.40
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
144.24%
-26.81
-10.98 -11.60 -11.54 -15.40
Net Income/Loss
144.24%
-26.81
-10.98 -11.60 -11.54 -15.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
91.52%
2.3747
28.01 0.014 27.98 27.97
Diluted Average Shares
91.52%
2.3747
28.01 0.014 27.98 27.97
Basic Earnings Per Share
2,795%
-11.29
-0.39 -0.41 -0.41 -0.55
Diluted Earnings Per Share
2,795%
-11.29
-0.39 -0.41 -0.41 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):